Metal-free radical transformation enables diverse synthesis of benzimidazole-fused heterocycles, suggesting new pathways for bioactive molecule diversification.
A metal-free radical tandem carbamoylation/cyclization strategy for the divergent synthesis of benzimidazole-fused heterocycles has been described. Using commercially available oxamic acids and imidazoles tethered with unactivated alkenes under mild conditions, this method provides the first efficient access to stable [6,5,7]- and [6,5,8]-fused frameworks along with [6,5,6] systems. It exhibits excellent functional group tolerance and broad substrate scope, including 2-heteroarylbenzimidazoles. Preliminary studies also revealed that monoalkyl oxalates can serve as effective radical precursors in this transformation, offering potential for further derivatization of the products. The method is also applicable to the late-stage diversification of bioactive molecules, such as theophylline.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: